Sign in

CIK 0000313143

  • Large accelerated filer

HAEMONETICS CORP

Sign in to watch
Ticker
HAE
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Apr 3
Incorporated
MA
Entity type
Operating
EIN
042882273
Phone
+1 781-848-7100
Business address
125 SUMMER STREET, BOSTON, MA, 02110
  1. 4 Open-market sale Director sold 4,337 shares at an average $35.14 ($152,398)
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 14,685 shares at an average $35.35 ($519,105)
  4. 4 Open-market buy President & CEO bought 60,000 shares at $35.00 ($2,099,754)
  5. 4 Grant or award Director acquired 5,746 shares (grant or award)
  6. 4 Grant or award Director acquired 5,746 shares (grant or award)
  7. 4 Grant or award Director acquired 5,746 shares (grant or award)
  8. 4 Grant or award Director acquired 5,746 shares (grant or award)
  9. 4 Grant or award Director acquired 5,746 shares (grant or award)
  10. 4 Grant or award President & CEO acquired 45,867 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award EVP, Global Manufacturing acquired 9,765 shares (grant or award)
  13. 4 Grant or award EVP, Global Human Resources acquired 8,138 shares (grant or award)
  14. 4 Grant or award EVP and Chief Legal Officer acquired 9,765 shares (grant or award)
  15. 4 Grant or award CFO & EVP Business Development acquired 11,393 shares (grant or award)
  16. 4 Grant or award President, Global Markets acquired 8,138 shares (grant or award)
  17. 4 Open-market sale President, Global Markets sold 344 shares at $32.13 ($11,052)
  18. 4 Open-market sale Chief Science and Technology sold 319 shares at $32.13 ($10,249)
  19. 4 Open-market sale EVP and Chief Legal Officer sold 778 shares at $32.13 ($24,996)
  20. 4 Open-market sale VP Finance sold 497 shares at $32.13 ($15,968)

Page 22 of 60 · 1,191 filings